Immediate Impact
1 from Science/Nature 60 standout
Citing Papers
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2023 Standout
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
2023 Standout
Works of L Paolozzi being referenced
Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension
2008
Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis
2006
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| L Paolozzi | 340 | 188 | 150 | 313 | 212 | 14 | 914 | |
| Nathan Bennett | 94 | 167 | 253 | 341 | 193 | 20 | 1.1k | |
| H. Desmurs‐Clavel | 110 | 116 | 146 | 133 | 134 | 21 | 802 | |
| J.N. Katz | 587 | 372 | 39 | 85 | 117 | 16 | 1.1k | |
| Allison Smitten | 552 | 49 | 77 | 128 | 79 | 9 | 1.0k | |
| C. Speirs | 443 | 58 | 47 | 155 | 80 | 9 | 873 | |
| Stig Lyngbæk | 83 | 227 | 57 | 133 | 364 | 20 | 1.0k | |
| E. Zuckerman | 224 | 208 | 26 | 67 | 108 | 30 | 1.0k | |
| Haewon C. Kim | 75 | 212 | 118 | 355 | 75 | 29 | 1.1k | |
| G. Thomas | 247 | 87 | 30 | 338 | 76 | 30 | 873 | |
| J.L. Navarro | 137 | 97 | 163 | 308 | 81 | 27 | 836 |
All Works
Loading papers...